Open-House Biologika Discount Contracts 2025-29-Omalizumab

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 119180463

  Document Type - Tender Notices

Description - Description: The companies involved pursue the goal of concluding discount contracts according to § 130a (8) SGB V with all suitable pharmaceutical entrepreneurs to the active ingredient omalizumab. The conclusion of the contract takes place as part of the open house biological procedure of the funds involved: Individual negotiations on contract content are not conducted, uniform conditions apply. The health insurance companies involved do not allow individual contractual partners to exclusiveness. The contract term is a maximum of 24 months starting on 01.11.2025. The contract ends at the latest on October 31, 2027, regardless of the date of the contract. All further information can be fou

Gt Ref Id - 119180463

Deadline - Oct 31, 2027